HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoko Baba Selected Research

Biomarkers (Surrogate Marker)

7/2022The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoko Baba Research Topics

Disease

9Neoplasms (Cancer)
07/2022 - 11/2003
3Schizophrenia (Dementia Praecox)
07/2018 - 01/2015
2Mental Disorders (Mental Disorder)
03/2013 - 09/2012
1Breast Neoplasms (Breast Cancer)
07/2022
1Neoplasm Metastasis (Metastasis)
03/2022
1Myxoid Liposarcoma
03/2022
1Histiocytosis
01/2022
1Papillary Carcinoma
07/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Hyperplasia
01/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Psychotic Disorders (Schizoaffective Disorder)
07/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2018
1Lymphoma (Lymphomas)
04/2018
1Adenoid Cystic Carcinoma (Cylindroma)
01/2018
1Adenocarcinoma of Lung
01/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2016
1Nausea
06/2015
1Vomiting
06/2015
1Infections
07/2003

Drug/Important Bio-Agent (IBA)

3Anaplastic Lymphoma KinaseIBA
01/2022 - 04/2016
3LigandsIBA
01/2019 - 09/2012
2Proteins (Proteins, Gene)FDA Link
03/2022 - 09/2012
2alectinibIBA
01/2019 - 01/2017
1Biomarkers (Surrogate Marker)IBA
07/2022
1Untranslated RNA (Noncoding RNA)IBA
07/2022
1Estrogen ReceptorsIBA
07/2022
1Messenger RNA (mRNA)IBA
03/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2022
1CalponinsIBA
06/2019
1VimentinIBA
06/2019
1N- acetylgalactosaminyl- 1- 4- N- acetylglucosamineIBA
01/2019
1ceritinibIBA
01/2019
1CrizotinibIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1lorlatinibIBA
01/2019
1Polysaccharides (Glycans)IBA
01/2019
1Prostate-Specific Antigen (Semenogelase)IBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Histone Deacetylase InhibitorsIBA
01/2019
1Pharmaceutical PreparationsIBA
12/2018
1Phosphotransferases (Kinase)IBA
10/2018
1Antipsychotic Agents (Antipsychotics)IBA
07/2018
1Dopamine (Intropin)FDA LinkGeneric
07/2018
1Factor XIIIaIBA
05/2018
1Keratins (Keratin)IBA
05/2018
1S100 Proteins (S 100 Protein)IBA
05/2018
1MART-1 AntigenIBA
05/2018
1Biological ProductsIBA
04/2018
1Histones (Histone)IBA
02/2018
1ParaffinIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2018
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2015
1Antidepressive Agents (Antidepressants)IBA
06/2015
1Paroxetine (Paxil)FDA LinkGeneric
06/2015
1Dopamine D3 ReceptorsIBA
03/2015
15-HT1A Serotonin ReceptorIBA
01/2015
1Risperidone (Risperdal Consta)FDA LinkGeneric
01/2015
1blonanserinIBA
01/2015
1tandospironeIBA
01/2015
1Haloperidol (Haldol)FDA LinkGeneric
01/2015
1NeurosteroidsIBA
03/2013
1HMGB1 Protein (HMG1)IBA
11/2003
1Viral ProteinsIBA
07/2003

Therapy/Procedure

2Therapeutics
01/2019 - 01/2015
1Thyroidectomy
07/2020